Cargando…
Antiviral Therapy of COVID-19
Since the beginning of the COVID-19 pandemic, the scientific community has focused on prophylactic vaccine development. In parallel, the experience of the pharmacotherapy of this disease has increased. Due to the declining protective capacity of vaccines against new strains, as well as increased kno...
Autores principales: | Gudima, Georgii, Kofiadi, Ilya, Shilovskiy, Igor, Kudlay, Dmitry, Khaitov, Musa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218869/ https://www.ncbi.nlm.nih.gov/pubmed/37240213 http://dx.doi.org/10.3390/ijms24108867 |
Ejemplares similares
-
Peculiarities of the T Cell Immune Response in COVID-19
por: Kudlay, Dmitry, et al.
Publicado: (2022) -
Identification of a novel splice variant for mouse and human interleukin-5
por: Shilovskiy, Igor, et al.
Publicado: (2020) -
IgE‐reactivity profiles to allergen molecules in Russian children with and without symptoms of allergy revealed by micro‐array analysis
por: Elisyutina, Olga, et al.
Publicado: (2020) -
Molecular and Cellular Mechanisms of Respiratory Syncytial Viral Infection: Using Murine Models to Understand Human Pathology
por: Shilovskiy, Igor P., et al.
Publicado: (2021) -
The Role of Interleukin-37 in the Pathogenesis of Allergic Diseases
por: Shilovskiy, I. P., et al.
Publicado: (2019)